Publications by authors named "V P Karapandzic"

Background: Historically, the treatment of choice for anal cancer had been abdominoperineal resection (APR). Radical radiotherapy with concurrent 5-fluorouracil plus mitomycin C chemotherapy was later established as standard therapy, although with a failure rate of 20-30%. The aim of this study was to evaluate the outcomes after radical chemoradiotherapy (CRT), prognostic and predictive factors and patterns of failure.

View Article and Find Full Text PDF
Article Synopsis
  • Up to 84% of cervical cancer patients undergoing radiotherapy experience acute radiation toxicity (ART), prompting a study to explore the effects of ACE inhibitors, β-blockers, and patient-specific risk factors on ART development.
  • The research includes two nested case-control studies examining risk factors for ART in patients receiving 3D conformal radiotherapy or 2D conventional radiotherapy, followed from January 2017 to September 2018 in a tertiary care setting.
  • Significant findings include that ACE inhibitors, bladder volume, BMI, and radiation dose to the bladder and rectum play crucial roles in ART occurrence, with ACE inhibitors linked to reduced ART risk in patients treated with 3D-CRT.
View Article and Find Full Text PDF

Background/aim: Posterior breast cancers are located in the prepectoral region of the breast. Owing to this distinctive anatomical localization, physical examination and mammographic or ultrasonographic evaluation can be difficult. The purpose of the study was to assess possibilities of diagnostic mammography and breast ultrasonography in detection and differentiation of posterior breast cancers.

View Article and Find Full Text PDF

The authors present the case of a nulliparous 34-year-old patient. At the tenth week of gestation, she developed phlebothrombosis of veins of the right leg and massive pulmonary embolism. After thrombolytic and heparin therapy she developed rethrombosis and heparin-induced thrombocytopenia type II.

View Article and Find Full Text PDF

Coronary artery disease is one of the risk factors for myocardial infarction and it is present in 40% of patients who are undergoing noncardiac surgery. Despite evidence of the benefit of the antiplatelet therapy in patients at risk of cardiac complications, aspirin treatment is often discontinued before surgery due to the risk of perioperative bleeding. In many studies and meta-analysis it is shown that aspirin withdrawal in perioperative period was associated with three-fold higher risk of major adverse cardiac events.

View Article and Find Full Text PDF